GILT REQUIRED FOR RTL550-CYS-MOG TO TREAT EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

MHC class II-derived recombinant T cell receptor ligands (RTLs) modulate the behavior of pathogenic T cells and can reverse clinical and histological signs of autoimmune disease in experimental autoimmune encephalomyelitis (EAE), experimental autoimmune uveitis (EAU) and collagen-induced arthritis (...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Burrows, Gregory G., Meza-Romero, Roberto, Huan, Jianya, Sinha, Sushmita, Mooney, Jeffrey L., Vandenbark, Arthur A., Offner, Halina
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348371/
https://ncbi.nlm.nih.gov/pubmed/22392628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-012-9289-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires